Leproust Emily M.'s Insider Trades & SAST Disclosures
Leproust Emily M.'s most recent trade in Twist Bioscience Corp was a trade of 1,726 Common Stock done at an average price of $41.7 . Disclosure was reported to the exchange on March 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leproust Emily M..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.68 per share. | 20 Mar 2025 | 1,726 | 660,966 (1%) | 0% | 41.7 | 71,933 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.91 per share. | 06 Mar 2025 | 2,402 | 662,692 (1%) | 0% | 40.9 | 98,273 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 21 Feb 2025 | 2,790 | 665,094 (1%) | 0% | 44.2 | 123,254 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.35 per share. | 03 Feb 2025 | 5,200 | 667,318 (1%) | 0% | 49.4 | 256,630 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.59 per share. | 03 Jan 2025 | 546 | 672,518 (1%) | 0% | 45.6 | 24,893 | Common Stock |
| Twist Bioscience Corp | Leproust M. Emily | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.90 per share. | 20 Dec 2024 | 1,654 | 673,064 (1%) | 0% | 44.9 | 74,270 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 06 Dec 2024 | 2,216 | 674,718 (1%) | 0% | 52.7 | 116,792 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 95,350 | 676,934 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 11 Nov 2024 | 7,968 | 581,584 (1%) | 0% | 48.0 | 382,448 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 06 Nov 2024 | 14,334 | 589,552 (1%) | 0% | 44.6 | 639,368 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.60 per share. | 06 Nov 2024 | 14,334 | 589,552 (1%) | 0% | 44.6 | 639,368 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 80,855 | 562,773 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2024 | 45,954 | 608,727 (1%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 04 Nov 2024 | 4,841 | 603,886 (1%) | 0% | 41.6 | 201,211 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 43.21 per share. | 02 Oct 2024 | 13,605 | 481,918 (1%) | 0% | 43.2 | 587,886 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.94 per share. | 20 Sep 2024 | 1,730 | 495,523 (1%) | 0% | 46.9 | 81,208 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.16 per share. | 06 Sep 2024 | 2,340 | 497,253 (1%) | 0% | 39.2 | 91,637 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 05 Aug 2024 | 5,139 | 499,593 (1%) | 0% | 39.9 | 205,180 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.00 per share. | 02 Jul 2024 | 1,114 | 504,732 (1%) | 0% | 48.0 | 53,474 | Common Stock |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 5,828 | 8,352 | - | 0 | Class A Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.41 per share. | 20 Jun 2024 | 1,732 | 505,846 (1%) | 0% | 49.4 | 85,578 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.33 per share. | 06 Jun 2024 | 2,408 | 507,578 (1%) | 0% | 51.3 | 123,600 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 03 May 2024 | 4,163 | 509,986 (1%) | 0% | 37.1 | 154,589 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.74 per share. | 02 Apr 2024 | 1,132 | 514,149 (1%) | 0% | 32.7 | 37,057 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.52 per share. | 20 Mar 2024 | 1,128 | 515,281 (1%) | 0% | 33.5 | 37,806 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 06 Mar 2024 | 1,487 | 516,409 (1%) | 0% | 37.4 | 55,658 | Common Stock |
| Twist Bioscience Corp | M. Leproust Emily | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.59 per share. | 02 Feb 2024 | 4,722 | 516,605 (1%) | 0% | 36.6 | 172,778 | Common Stock |
| Twist Bioscience Corp | M. Leproust Emily | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.86 per share. | 02 Jan 2024 | 1,181 | 521,327 (1%) | 0% | 36.9 | 43,532 | Common Stock |
| Twist Bioscience Corp | Emily Leproust M. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.33 per share. | 19 Dec 2023 | 1,722 | 522,508 (1%) | 0% | 38.3 | 66,004 | Common Stock |
| Twist Bioscience Corp | Leproust Emily M. | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.67 per share. | 05 Dec 2023 | 2,329 | 524,230 (1%) | 0% | 24.7 | 57,456 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share. | 18 Aug 2023 | 2,787 | 246,785 (0%) | 0% | 19.5 | 54,235 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.09 per share. | 24 Jul 2023 | 898 | 249,572 (0%) | 0% | 25.1 | 22,531 | Common Stock |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 8,816 | 8,816 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2023 | 5,828 | 5,828 | - | - | Restricted Stock Unit | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.46 per share. | 30 Jun 2023 | 1,122 | 250,470 (0%) | 0% | 20.5 | 22,956 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.31 per share. | 16 Jun 2023 | 1,748 | 251,592 (0%) | 0% | 18.3 | 32,006 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 64,950 | 64,950 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.03 per share. | 19 May 2023 | 2,754 | 253,340 (0%) | 0% | 13.0 | 35,885 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 24,360 | 0 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 04 May 2023 | 24,360 | 256,094 (0%) | 0% | 6.0 | 144,942 | Common Stock |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2023 | 45,454 | 83,290 | - | 0 | Class A Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.63 per share. | 24 Apr 2023 | 898 | 231,734 (0%) | 0% | 13.6 | 12,240 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.08 per share. | 31 Mar 2023 | 1,121 | 232,632 (0%) | 0% | 15.1 | 16,905 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.51 per share. | 17 Mar 2023 | 1,748 | 233,753 (0%) | 0% | 16.5 | 28,859 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.52 per share. | 17 Feb 2023 | 2,741 | 234,868 (0%) | 0% | 22.5 | 61,727 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.74 per share. | 24 Jan 2023 | 980 | 237,609 (0%) | 0% | 28.7 | 28,165 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.81 per share. | 03 Jan 2023 | 628 | 239,079 (0%) | 0% | 23.8 | 14,953 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.81 per share. | 03 Jan 2023 | 490 | 238,589 (0%) | 0% | 23.8 | 11,667 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 59,758 | 239,707 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.81 per share. | 18 Nov 2022 | 2,762 | 179,949 (0%) | 0% | 24.8 | 68,525 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.08 per share. | 24 Oct 2022 | 923 | 182,711 (0%) | 0% | 29.1 | 26,841 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 627 | 184,120 (0%) | 0% | 35.2 | 22,095 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. | 30 Sep 2022 | 486 | 183,634 (0%) | 0% | 35.2 | 17,127 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.81 per share. | 19 Aug 2022 | 2,812 | 184,747 (0%) | 0% | 42.8 | 120,382 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.52 per share. | 22 Jul 2022 | 913 | 187,559 (0%) | 0% | 43.5 | 39,734 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.08 per share. | 01 Jul 2022 | 1,111 | 188,472 (0%) | 0% | 37.1 | 41,196 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.99 per share. | 20 May 2022 | 2,783 | 189,583 (0%) | 0% | 37.0 | 102,943 | Common Stock |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 78,914 | 78,914 | - | - | Stock Option | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp - Ord... | Emily M. Leproust | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 37,836 | - | - | Class A Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.21 per share. | 22 Apr 2022 | 923 | 192,366 (0%) | 0% | 34.2 | 31,576 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.91 per share. | 01 Apr 2022 | 1,108 | 193,289 (0%) | 0% | 52.9 | 58,624 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.21 per share. | 18 Feb 2022 | 2,837 | 194,165 (0%) | 0% | 53.2 | 150,957 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.87 per share. | 24 Jan 2022 | 1,008 | 197,002 (0%) | 0% | 55.9 | 56,317 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.39 per share. | 18 Jan 2022 | 579 | 198,010 (0%) | 0% | 77.4 | 44,809 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 18 Jan 2022 | 286 | 198,589 (0%) | 0% | 60.0 | 17,169 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 18 Jan 2022 | 286 | 198,875 (0%) | 0% | 8.8 | 2,523 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 286 | 150,879 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2021 | 16,845 | 176,408 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.12 per share. | 27 Dec 2021 | 1,962 | 162,901 (0%) | 0% | 80.1 | 157,195 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 80.86 per share. | 27 Dec 2021 | 1,938 | 160,963 (0%) | 0% | 80.9 | 156,706 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Dec 2021 | 1,150 | 164,863 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 81.83 per share. | 27 Dec 2021 | 1,100 | 159,863 (0%) | 0% | 81.8 | 90,013 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 82.43 per share. | 27 Dec 2021 | 200 | 159,663 (0%) | 0% | 82.4 | 16,486 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.80 per share. | 27 Dec 2021 | 100 | 159,563 (0%) | 0% | 83.8 | 8,380 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 6,960 | 35,893 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 08 Dec 2021 | 6,960 | 172,973 (0%) | 0% | 6.0 | 41,412 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 83.03 per share. | 08 Dec 2021 | 3,009 | 169,964 (0%) | 0% | 83.0 | 249,846 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 88.62 per share. | 08 Dec 2021 | 2,851 | 166,013 (0%) | 0% | 88.6 | 252,657 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 84.31 per share. | 08 Dec 2021 | 1,100 | 168,864 (0%) | 0% | 84.3 | 92,743 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.62 per share. | 19 Nov 2021 | 2,829 | 166,013 (0%) | 0% | 110.6 | 312,944 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 10,440 | 42,853 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 15 Nov 2021 | 10,440 | 179,282 (0%) | 0% | 6.0 | 62,118 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 115.68 per share. | 15 Nov 2021 | 6,676 | 168,842 (0%) | 0% | 115.7 | 772,309 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 114.73 per share. | 15 Nov 2021 | 3,764 | 175,518 (0%) | 0% | 114.7 | 431,855 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 04 Nov 2021 | 8,208 | 177,050 (0%) | 0% | 8.8 | 72,395 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 8,208 | 164,014 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 138.77 per share. | 04 Nov 2021 | 8,208 | 168,842 (0%) | 0% | 138.8 | 1,139,037 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 139.39 per share. | 04 Nov 2021 | 1,501 | 168,842 (0%) | 0% | 139.4 | 209,218 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 04 Nov 2021 | 1,501 | 170,343 (0%) | 0% | 8.8 | 13,239 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2021 | 1,501 | 162,513 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 8,866 | 177,806 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 02 Nov 2021 | 8,866 | 180,412 (0%) | 0% | 8.8 | 78,198 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 129.00 per share. | 02 Nov 2021 | 8,641 | 171,771 (0%) | 0% | 129.0 | 1,114,678 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 5,584 | 172,222 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.82 per share. | 02 Nov 2021 | 5,584 | 182,050 (0%) | 0% | 8.8 | 49,251 | Common Stock |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 5,220 | 53,293 | - | - | Employee Stock Option (right to buy) | |
| Twist Bioscience Corp | Emily M. Leproust | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.95 per share. | 02 Nov 2021 | 5,220 | 176,466 (0%) | 0% | 6.0 | 31,059 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges